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Abstract
Background: The cellular prion protein, PrP
C, is GPI anchored and abundant in lipid rafts. The absolute requirement of PrP
C
in neurodegeneration associated to prion diseases is well established. However, the function of this ubiquitous protein is
still puzzling. Our previous work using the 1C11 neuronal model, provided evidence that PrP
C acts as a cell surface receptor.
Besides a ubiquitous signaling function of PrP
C, we have described a neuronal specificity pointing to a role of PrP
C in
neuronal homeostasis. 1C11 cells, upon appropriate induction, engage into neuronal differentiation programs, giving rise
either to serotonergic (1C11
5-HT) or noradrenergic (1C11
NE) derivatives.
Methodology/Principal Findings: The neuronal specificity of PrP
C signaling prompted us to search for PrP
C partners in
1C11-derived bioaminergic neuronal cells. We show here by immunoprecipitation an association of PrP
C with an 80 kDa
protein identified by mass spectrometry as the tissue non-specific alkaline phosphatase (TNAP). This interaction occurs in
lipid rafts and is restricted to 1C11-derived neuronal progenies. Our data indicate that TNAP is implemented during the
differentiation programs of 1C11
5-HT and 1C11
NE cells and is active at their cell surface. Noteworthy, TNAP may contribute to
the regulation of serotonin or catecholamine synthesis in 1C11
5-HT and 1C11
NE bioaminergic cells by controlling pyridoxal
phosphate levels. Finally, TNAP activity is shown to modulate the phosphorylation status of laminin and thereby its
interaction with PrP.
Conclusion/Significance: The identification of a novel PrP
C partner in lipid rafts of neuronal cells favors the idea of a role of
PrP in multiple functions. Because PrP
C and laminin functionally interact to support neuronal differentiation and memory
consolidation, our findings introduce TNAP as a functional protagonist in the PrP
C-laminin interplay. The partnership
between TNAP and PrP
C in neuronal cells may provide new clues as to the neurospecificity of PrP
C function.
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Introduction
The cellular prion protein PrP
C is a ubiquitous glycoprotein
anchored at the plasma membrane through a glycosylpho-
sphatidylinositol (GPI) lipid moiety. It is abundantly expressed in
neurons of the central nervous system (CNS), which are the main
target of transmissible spongiform encephalopathies (TSE). The
conversion of PrP
C into an abnormal conformer, PrP
Sc, prone to
aggregation, is a hallmark of prion diseases. In addition to having a
genetic or sporadic origin like other neurodegenerative disorders,
prion diseases have the unique peculiarity to be transmissible, the
PrP
Sc conformer being the main if not the only component of the
pathogenic agent [1].
The absolute requirement of PrP
C for the development of prion
diseases is well established. However, the precise role of this
protein is yet to be fully determined. Its identification should help
to understand how the pathogenic isoforms interfere with the
cellular function of normal PrP
C [2]. Recent data have shown that
PrP
C plays a role in cell signaling and cell adhesion and may act as
a membrane receptor or co-receptor [3–5], consistent with its
PLoS ONE | www.plosone.org 1 August 2009 | Volume 4 | Issue 8 | e6497extra-cellular orientation. Interestingly, PrP
C is expressed at the
plasma membrane in sub-domains enriched in cholesterol and
sphingolipid [6] described as rafts and known to play a role in
cellular events such as sorting of membrane constituents and signal
transduction [7]. While the location of PrP
C in lipid rafts is
suspected to be required for its conversion into PrP
Sc [8,9], it could
also have implications as to PrP
C function.
Attempts to identify physiological ligands or partners that could
bring light on PrP
C function have relied on different approaches
(two hybrid techniques, immunoprecipitation of cellular PrP
C
complexes, complementary hydropathy analyses…). Only some of
the interactions have been confirmed and/or shown to have
functional relevance at a cellular level [10]. PrP
C associates with
molecular chaperones such as BiP, grp94, protein disulfide
isomerase or calnexin, required for the proper folding of
glycoproteins [11]. Another PrP
C-interacting molecule is the stress
inducible protein I (STI-I) chaperone, described as having a
neuroprotective action [12]. PrP
C partners also include proteins
involved in signal transduction such as synapsin 1, important for
synapse formation and neurotransmitter release, the adaptor Grb2
molecule [13] and the protein casein kinase 2, CK2 [14]. Also,
adhesion molecules such as laminin and the 37/67 kDa laminin
receptor have been shown to interact with PrP
C [15–17], with
heparan sulphated molecules acting as intermediates [18]. Graner
et al. have notably reported on the impact of the PrP
C-laminin
interaction on neurite outgrowth [16]. Chemical cross-linking
analyses have identified the neuronal adhesion molecule, NCAM,
as another PrP
C interacting protein [19]. This interaction appears
to sustain the recruitment of NCAM into lipid rafts, the activation
of the Fyn tyrosine kinase and N-CAM-mediated neurite
outgrowth [20]. The latter observation recalls our demonstration
that antibody mediated PrP
C cross-linking triggers Fyn activation
in 1C11-derived neuronal cells via the lipid raft protein caveolin
[3].
In order to search for PrP
C partners, we took advantage of the
1C11 neuronal differentiation model [21], which previously
allowed us to substantiate a role for PrP
C in signal transduction.
Upon appropriate induction, the 1C11 neuroepithelial cell line
engages into a neuronal differentiation program. Nearly 100%
cells acquire the overall functions of serotonergic (1C11
5-HT)o r
noradrenergic (1C11
NE) neurons, within 4 or 12 days, respectively.
By unraveling some signal transduction events instructed by PrP
C,
our previous work has pointed to the implication of the cellular
prion protein in cell homeostasis [3,22–24]. In 1C11
5-HT and
1C11
NE differentiated cells, the implementation of a PrP
C-
caveolin-Fyn platform on neuritic extensions controls multiple
pathways converging to the MAP kinases, ERK1/2. Furthermore,
in addition to its proper signaling activity, PrP
C modulates the
agonist-induced response of the three serotonin receptors coupled
to G-proteins present on 1C11
5-HT cells, themselves regulating the
overall serotonergic functions [25]. Interestingly, this modulatory
role of PrP
C is also restricted to fully differentiated cells and is
caveolin-dependent.
The neuronal specificity of PrP
C signaling function may rely on
some of the numerous isoforms and/or glycoforms of this protein
resulting from proteolytic cleavage and heterogenous glycosylation
[26,27]. It could also depend on PrP
C partners induced during the
bioaminergic programs and/or recruited into lipid rafts. The
purpose of the present study was to search for PrP
C partners in
lipid microdomains of differentiated neuronal cells. By an
approach combining immunoprecipitation of PrP
C from lipid
rafts and mass spectrometry analysis, we identify the tissue non-
specific alkaline phosphatase (TNAP) as interacting with PrP
C in
membrane microdomains of both 1C11
5-HT and 1C11
NE cells.
TNAP is a GPI membrane-bound alkaline phosphatase (AP)
expressed as three distinct isoforms found respectively in liver,
kidney and at a high level in bone where it plays an essential role
in osteogenesis [28]. Recent data identified TNAP in different cell
types of the brain [29,30]. While its role is still elusive, it has been
proposed to participate to neurotransmission [29].
Here, we show that TNAP is induced along either the
serotonergic or noradrenergic differentiation program of 1C11
cells. This ectoenzyme is active under physiological conditions and
may participate in bioamine synthesis. Besides, we provide
evidence that the PrP
C-interacting protein laminin is a substrate
for TNAP in 1C11-derived neuronal cells, and that, by
modulating the phosphorylation level of laminin, TNAP impacts
on the interaction between PrP and laminin.
Results
PrP
C partitions in lipid rafts irrespective of the
differentiation state of 1C11 cells
The presence of PrP
C in lipid rafts of 1C11 precursor, 1C11
5-HT
or 1C11
NE fully differentiated cells, was assessed using TritonX-
100 insoluble glycosphingolipid (GSL) rich microdomains isolated
by flotation on sucrose gradient and solubilized in 6% SDS. As
revealed by Western blot, PrP
C majorly segregated into the GSL
fraction of 1C11 cells (Fig. 1A) and its neuronal progenies (not
shown). A similar result was obtained for caveolin 1, a marker of
caveolae which are subtypes of lipid rafts (Fig. 1B).
To evaluate the degree of PrP
C enrichment in lipid rafts,
comparative analyses were performed by Western blot using
proteins of raft preparations (1 mg) and total extracts (15 mg) from
1C11 precursor, 1C11
5-HT (day 4) and 1C11
NE (day 12) cells.
Irrespective of the differentiation state, a 100- to 200-fold increase
in the amount of PrP
C was observed in GSL fractions (Fig. 2A). A
similar enrichment was observed for other proteins specific of lipid
rafts such as flotillin (Fig. 2B), caveolin 1 (Fig. 1B and not shown)
and the GPI-anchored 120 kDa isoform of NCAM (Fig. 2C), the
latter two described as interacting with PrP
C [3,19]. While
NCAM120 was enriched in lipid rafts, it is noteworthy that the
140 kDa transmembrane form of NCAM was predominant in
total extracts.
These data indicate that the enrichment of PrP
C in lipid rafts is
independent from the differentiation state, precursor vs neuronal,
of 1C11 cells.
PrP
C interacts in microdomains of 1C11
5-HT and 1C11
NE
neuronal cells with an 80 kDa protein identified as the
tissue non-specific alkaline phosphatase, TNAP
In order to seach for potential PrP
C partners in such specialized
microdomains, plasma membrane proteins of 1C11, 1C11
5-HT
and 1C11
NE cells were labelled with biotin before raft preparation.
GSL fractions were dissolved in non ionic detergent (1% TritonX-
100) to maintain some protein interactions and heated for 1 hour
at 37uC to allow extraction of proteins from membrane
cholesterol. Antibodies recognizing either N-ter (SAF34) or C-ter
(Bar221) epitopes of PrP
C were covalently linked to sepharose
beads and used to immunoprecipitate PrP
C. The immunoprecip-
itated complexes were resolved on a 12% SDS-PAGE (Fig. 3A).
The biotinylated full-length mono or bi-glycosylated PrP
C species
were immunoprecipitated with both antibodies in 1C11
5-HT
differentiated cells as well as in 1C11 precursor cells. The
glycoforms corresponding to the N-terminally truncated fragments
of PrP
C were recovered with the Bar221 antibody only. A few
other biotinylated proteins appeared to be co-precipitating with
PrP
C both in 1C11 precursor cells and in bioaminergic neuronal
TNAP, a Neuronal PrPC Partner
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between 45–65 kDa (fig. 3A and B) as well as proteins of high
molecular weight (around 200 kDa). Interestingly, using either
anti-N-ter or anti-C-ter PrP
C antibodies, an 80 kDa biotinylated
protein was co-precipitated with PrP
C in lipid rafts of 1C11
5-HT
and 1C11
NE cells. The presence of this 80 kDa protein within
PrP
C complexes appears to depend on neuronal differentiation,
since we failed to detect this protein co-precipitating with PrP
C in
lipid rafts of the 1C11 neuroepithelial precursor (Fig. 3 and data
not shown).
Mass spectrometry analysis was then carried out to define the
identity of this 80 kDa PrP
C partner. Lipid rafts were prepared
from 1C11
5-HT and 1C11
NE cells as well as from 1C11 precursor.
PrP
C complexes were immunoprecipitated as above and separated
on an 8% SDS-PAGE allowing a better resolution in the 50–
100 kDa range of proteins as exemplified in Figure 3B. Proteins of
80 kDa apparent molecular mass were trypsin-digested and
analyzed with a LC/MS/MS instrument. The experimental
peptide fragments were confronted to the NCBI non-redundant
mouse database. Five peptides (aa53–71,a a 204–213,a a 248–260,a a 274–
282,a a 370–392) that matched different regions of the TNAP
sequence (Fig. 4) were identified with a high score (60.17) in
1C11
5-HT and 1C11
NE cells. In contrast, TNAP peptides were not
detected in immunoprecipitates from 1C11 precursor cells.
Figure 1. PrP
C partitions in lipid rafts of 1C11 cells. Proteins (10 mg) from different fractions of 1C11 cells isolated on a discontinuous sucrose
gradient, i.e. total homogenate (HT), the 30% (F30) and 40% (F40) soluble layers, insoluble pellet (HSP) and the raft (GSL) fraction, were separated ona
12% SDS-PAGE and analyzed by western blotting. The presence of PrP
C (A) and caveolin 1 (B) was assessed using SAF32 and C060 monoclonal
antibodies, respectively. Arrows indicate the different forms of PrP
C (non-, mono and biglycosylated) and the a and b chains of caveolin 1.
doi:10.1371/journal.pone.0006497.g001
Figure 2. PrP
C is enriched in lipid rafts irrespective of the differentiated state of 1C11 cells. Proteins of total extracts (15 mg) and lipid
rafts (1 mg) from 1C11 cells, their neuronal 1C11
5-HT and 1C11
NE derivatives, and Bw5147 lymphoid cells (used as control) were resolved by 12% SDS-
PAGE and analyzed by Western blot. Detection of PrP
C (A) and other raft markers, i.e. flotillin (B), the NCAM isoforms (C) and Lck kinase (D). A 100- to
200-fold increase in the amount of PrP
C, flotillin and the GPI-anchored 120 kDa isoform of NCAM was observed in GSL fractions in 1C11 cells whatever
their differentiation state. As expected, Lck kinase, was only present in lipid rafts of lymphoid cells. Of note, the B, C and D panels were obtained by
stripping and reprobing the same blotted nitrocellulose membrane.
doi:10.1371/journal.pone.0006497.g002
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study the TNAP-PrP
C interaction. Performing the reverse
immunoprecipitation with the anti-TNAP antibody did not allow
a clear detection of associated proteins (data not shown). The anti-
TNAP polyclonal antibody may promote a destabilisation of
TNAP-PrP
C complexes. It is also worth noting that under
conditions where biotinylated TNAP was easily revealed in PrP
C
immune-complexes by streptavidin, the anti-TNAP antibody
failed to yield a signal at 80 kDa. This suggests that sensitive
technics (biotinylation, mass spectrometry analysis) are required to
reveal TNAP co-precipitating with PrP
C.
We next evaluated the distribution of TNAP at the cell surface
of 1C11
5-HT serotonergic cells by immunofluorescence. TNAP
antibodies yielded a punctate staining of the membrane, both on
cell bodies and on neurites (Fig. 5, B and E). Such a labeling was
reminiscent of the PrP
C staining (Fig. 5, A and D). The
superimposition of the two stainings showed a partial co-
localization of TNAP and PrP
C at the surface of 1C11
5-HT
neuronal cells (Fig. 5C) that is confirmed by scanning confocal
analysis (fig. 5F).
As a whole, these data introduce TNAP as a neurospecific PrP
C
partner, in lipid rafts of either 1C11 serotonergic or noradrenergic
progenies. They also indicate that membrane-bound TNAP and
PrP
C are located in close vicinity within raft domains.
TNAP expression is restricted to 1C11
5-HT serotonergic
and 1C11
NE neuronal cells
The restriction of TNAP interaction with PrP
C to neuronal
1C11
5-HT and 1C11
NE cells prompted us to investigate whether
TNAP was present in microdomains of 1C11 precursor cells.
Direct LC/MS/MS analysis of trypsin-digested 80 kDa raft
components did not allow the identification of any peptides
Figure 3. PrP
C interacts with a 80 kDa protein in microdomains of 1C11
5-HT and 1C11
NE neuronal cells. Lipid rafts from 1C11
5-HT, 1C11
NE
and 1C11 precursor cells were prepared after biotinylation of membrane proteins. PrP
C was immunoprecipitated either with an anti-N-ter monoclonal
antibody (SAF34) or an anti-C-ter antibody (Bar221) covalently linked to sepharose beads. The biotinylated PrP
C complexes were separated on a 12%
SDS-PAGE to visualize all the PrP
C species (A) and on an 8% gel to better separate PrP
C co-immunoprecipitated protein of higher apparent molecular
mass (B). Biotinylated proteins were revealed with streptavidin peroxidase conjugate. The 80 kDa protein that co-immunoprecipitates with PrP
C in
1C11
5-HT is indicated by an arrow.
doi:10.1371/journal.pone.0006497.g003
Figure 4. The 80 kDa PrP
C partner is identified as TNAP by mass spectrometry. The position of the 5 peptides identified by mass
spectrometry (LC/MS/MS) with the best scores, is highlighted along the mouse TNAP protein sequence.
doi:10.1371/journal.pone.0006497.g004
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while it firmly confirmed the presence of TNAP in microdomains
of serotonergic and noradrenergic differentiated cells. Indeed,
three (aa53–71,a a 370–391,a a 392–407) and five (aa53–71,a a 247–257,
aa273–282,a a 370–391,a a 392–407) TNAP derived-peptides were
respectively identified in microdomains of serotonergic (score of
40.2) and noradrenergic (score of 70.3) neuronal cells (see Fig. 4
for residues numbering). In addition, Western blot analysis using a
TNAP specific antibody [31] also revealed a unique band of
80 kDa apparent molecular mass in the rafts of 1C11
5-HT and
1C11
NE cells, which was absent in 1C11 precursor cells (Fig. 6A).
The absence of the TNAP protein in 1C11 cells correlated with
a lack of TNAP gene expression as assessed by RT-PCR analysis.
As shown in Figure 6B, TNAP transcripts were below detectable
levels in the 1C11 precursor and were abundant in 1C11
5-HT and
1C11
NE neuronal cells.
As a whole, these results show that 1C11 precursor cells lack
TNAP and that the expression of this ectoenzyme is restricted to
1C11
5-HT and 1C11
NE neuronal cells.
A functional TNAP is induced during the differentiation
of 1C11
5-HT and 1C11
NE cells
We next investigated whether the TNAP interacting with PrP
C
at the cell surface of 1C11
5-HT and 1C11
NE cells was functional.
To preserve at best the TNAP ectoenzyme natural microenviron-
ment, we developped a chemiluminescence assay using the CSPD
probe. It allowed us to measure under physiological conditions,
TNAP and other phosphatase activities present at the cell surface
of adherent live cells. As shown in Figure 6C (white bars),
phosphatase activities monitored in 1C11 precursor cells were
much lower (3 to 4 fold) than in fully differentiated 1C11
5-HT
neuronal cells. We sought to specify whether the increase in
phosphatase activity associated to neuronal differentiation could
be attributed to TNAP. To this purpose, the chemiluminescent
assay was performed in the presence of orthovanadate (1 mM), a
phosphatase inhibitor with broad specificity, or tetramisol (5 mM),
a specific inhibitor of the TNAP enzyme. Interestingly, TNAP has
the particularity of being inhibited by tetramisol but not by
orthovanadate [32]. While not affected by tetramisol (grey bar),
exposure of 1C11 undifferentiated cells to orthovanadate (black
bar) fully switched off the phosphatase activity indicating that a set
of phosphatases, distinct from TNAP, is present at the neuroec-
todermal precursor stage. By contrast, in 1C11
5-HT serotonergic
cells, tetramisol inhibited around 65% of phosphatase activities.
The remaining activity corresponded roughly to the level already
present in undifferentiated 1C11 cells (Fig. 6C). Noticeably, in
1C11
5-HT cells, around 65% of the phosphatase activity which is
resistant to orthovanadate fully relates to TNAP. Similar
phosphatase profiles were obtained with 1C11
NE cells (see Fig. 7B).
The time of onset of a functional TNAP among total
phosphatase enzymatic activity was then monitored during the
kinetics of serotonergic and noradrenergic differentiation of 1C11
cells (Fig. 7). This is rendered possible by the synchronicity and the
homogeneity of differentiation of 1C11 cells. In 1C11
5-HT
serotonergic and 1C11
NE noradrenergic differentiating cells,
phosphatase activity levels kept increasing during the time course
of both neuronal differentiation programs, till completion (day 4
for 1C11
5-HT and day 12 for 1C11
NE cells). Such an increase in
cell surface phosphatase activities was majorly attributable to an
induction of TNAP as demonstrated by sensitivity to tetramisol
(Fig. 7A and B). This TNAP activity accounted for 60–70% of
total phosphatase activities in differentiated cells. Of note, the
induction of a TNAP enzymatic activity during 1C11 bioaminer-
gic differentiation fully matches the kinetics of expression of TNAP
specific mRNA (Fig. 7C).
These results demonstrate that a functional TNAP is induced as
early as day 3 of both the serotonergic and noradrenergic neuronal
pathways and reaches a maximal activity upon implementation of
a complete bioaminergic phenotype. The onset of TNAP activity
at the surface of bioaminergic cells, which precedes the
implementation of a complete phenotype, may confer to this
phosphatase a role in the modulation of neuron- or neurotrans-
mitter-associated specialized functions.
TNAP is involved in the control of serotonin and
catecholamines synthesis
The specific role of TNAP in the CNS is still elusive. TNAP is
known to function as an ectoenzyme to convert pyridoxal
phosphate (PLP) into pyridoxal (PL), ensuring the passive uptake
of this non-phosphorylated form of vitamin B6 into the cells where
PL is converted back to PLP by intracellular kinases. In neuronal
cells, PLP is an essential cofactor of the decarboxylases required
for neurotransmitter synthesis i.e. glutamate decarboxylase (GAD)
for GABA and amino acid decarboxylase (AADC) for bioamines.
To date, an involvement of TNAP has been inferred in
GABAergic neurotransmission only [33]. A potential link between
a TNAP–dependent control of vitamin B6 metabolism and
serotonin (5-HT) or catecholamine (CA) levels has not been
established. We evaluated the impact of TNAP inhibition on 5-
HT and CA synthesis in 1C11
5-HT and 1C11
NE cells. Cells having
Figure 5. Co-localization of PrP
C and TNAP at the surface of
1C11
5-HT cells. Membrane immunofluorescence was performed on
1C11
5-HT live cells cultured on glass coverslips. PrP
C (A and D) was
stained with the monoclonal SAF32 antibody and TNAP (B and E) with
polyclonal anti-TNAP antibodies and revealed with alexa green or red
labeled secondary antibodies, respectively. A superimposition of the
two fluorescence labelings is shown in panels (C) and (F). Panels (A), (B)
and (C) were obtained by epifluorescence and (D), (E) and (F) were
obtained by sequential acquisition on a scanning confocal microscope.
doi:10.1371/journal.pone.0006497.g005
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evaluated in 1C11
5-HT (A) and 1C11
NE (B) cells during the kinetics of differentiation. The histograms represent the level of phosphatase activity (RLU/
mg prot/h) monitored without (white bars) or with orthovanadate (black bars) or tetramisol (grey bars) phosphatase inhibitors. The amount of mRNA
transcripts specific of TNAP are shown in panel (C).
doi:10.1371/journal.pone.0006497.g007
Figure 6. The expression of a functional TNAP is restricted to differentiated serotonergic and noradrenergic 1C11 derived-cells. In
(A), the presence of TNAP in 1 mg of lipid rafts prepared from 1C11 induced or not to differentiate was revealed by western blot analysis using an anti-
TNAP specific antibody. In (B), the expression of TNAP mRNAs was evaluated by PCR analysis. TNAP (upper panel) or GAPDH (lower panel) specific
fragments were obtained after amplification by PCR of cDNA synthesized from mRNA isolated from the 1C11 precursor and the differentiated 1C11
5-
HT and 1C11
NE cells. In (C), phosphatase activity at the surface of 1C11 and 1C11
5-HT cells was measured by luminescence using the CSPD substrate
and expressed as relative luminescent unit (RLU). White bars correspond to total phosphatase activities, black bars to the activity measured in the
presence of 1 mM orthovanadate and grey bars in the presence of 5 mM tetramisol.
doi:10.1371/journal.pone.0006497.g006
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5-HT and day
12 for 1C11
NE) were exposed to tetramisol (2.5 mM) for up to
6 hours and cell extracts were collected at various time-points to
measure the levels of bioamines and their precursors.
As shown in Figure 8, tetramisol promoted a significant
decrease in 5-HT (2 fold) or dopamine (DA) (1.8 fold), i.e. the
AADC products, concomitant with an increase of their precursors
5-hydroxytryptophan (5-HTP) and dihydroxyphenylalanine (DO-
PA), respectively. This effect was observed as soon as 1 h, peaked
after 2 h, remained stable over 6 h (Fig. 8A and B) and vanished
after an overnight treatment (data not shown).
These data provide direct evidence that TNAP activity may act
on 5-HT and CA synthesis in 1C11
5-HT and in 1C11
NE cells and
define TNAP as a player in neurotransmitter metabolism.
TNAP modulates the phosphorylation state of laminin
and its binding to PrP
C, in both 1C11
5-HT and 1C11
NE cells
While TNAP activity on phospho-monoesters is well estab-
lished, there are only few reports suggesting that TNAP could act
on phospho-proteins. TNAP might in fact exert opposite action to
ecto-kinases on extracellular matrix (ECM) substrates. Based on
this assumption, we probed the impact of TNAP inactivation on
the phosphorylation of laminin, selected as a read out as both a
target of ecto-kinases [34] and a PrP
C-partner [16]. As shown in
figure 9A, laminin was barely phosphorylated in 1C11, 1C11
5-HT
and 1C11
NE control cells. As anticipated from the lack of TNAP
expression in 1C11 precursor cells, the level of laminin
phosphorylation was insensitive to tetramisol. In contrast,
exposure of 1C11
5-HT and 1C11
NE bioaminergic neuronal cells
to 2.5 mM tetramisol promoted a raise in laminin phosphoryla-
tion. A five fold increase in the amount of phospho-laminin was
quantified at 24 h, that persisted over 48 h in 1C11
5H-T and
1C11
NE treated cells vs untreated cells (fig. 9B).
Immunoprecipitation experiments were further carried out to
evaluate the possible impact of laminin phosphorylation on its
interaction with PrP
C. In agreement with the work of Graner [16],
PrP
C was found to associate with laminin in 1C11
5-HT and
1C11
NE cells (fig. 9C, left panel). Upon exposure of 1C11
5-HT and
1C11
NE cells to 2.5 mM tetramisol for 24 h, the interaction
between laminin and PrP was nearly lost (fig. 9C, right panel). As a
whole, these results identify laminin as a target of the PrP
C-
interacting partner TNAP in neuronal cells. We may also conclude
that, by modulating the phosphorylation level of laminin, TNAP
impacts on the interaction between PrP
C and laminin.
Discussion
In the present work, we identify the tissue non-specific alkaline
phosphatase, TNAP, as a partner of PrP
C in lipid microdomains of
1C11-derived bioaminergic neuronal cells. This was established
through co-immunoprecipitation and mass spectrometry analyses.
Three major observations relate to this partnership: (i) the PrP
C-
TNAP interaction is restricted to the 1C11
5-HT and 1C11
NE
neuronal progenies, (ii) it occurs in lipid rafts where both
protagonists, which are GPI-anchored, preferentially reside, and,
(iii) inhibition of TNAP activity alters the phosphorylation state of
the PrP
C-binding protein laminin, suggesting that PrP and TNAP
could functionally interact.
The 1C11 neuronal differentiation model used in the present
study has already allowed to gain information on PrP
C function.
Besides a ubiquitous intracellular signaling coupled to PrP
C
involved in red-ox equilibrium and cell homeostasis [22], our
previous findings have uncovered some neuronal specific function
of PrP
C. This first relates to the selective implementation of a
PrP
C-caveolin-Fyn platform governing several signaling pathways
converging on ERK1/2 in the differentiated 1C11
5-HT and
1C11
NE neuronal cells [3,22]. A second neurospecific role of
PrP
C is to modulate serotonin receptor intracellular coupling and
crosstalks [25]. Remarkably, both the proper instruction of signal
transduction events by PrP
C and its interference with serotonin
receptor responses involve caveolin. These observations illustrate
Figure 8. Involvement of TNAP in serotonin and catecholamine synthesis. (A) The intracellular content of 5-HT and its precursor 5-
hydroxytryptophan (5-HTP) were measured in 1C11
5-HT cells treated with 2.5 mM tetramisol for up to 6 h. (B) 1C11
NE cells were exposed to 2.5 mM
tetramisol for up to 6 h and their intracellular content of dopamine (DA) and its precursor dihydroxyphenylalanine (DOPA) were measured and
expressed as pmoles/mg of total protein. Data represent the means 6 S.E. of three independent experiments performed in triplicate.
doi:10.1371/journal.pone.0006497.g008
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C location in a subtype of lipid
rafts, the caveolae, involved in cell signaling and capable of
internalizing membrane receptors. However, the cellular and
molecular basis accounting for PrP
C neurospecific function still has
to be characterized. It could rely on the recruitment of a selective
subset of PrP
C isoforms in lipid rafts. An alternative explanation
would be the involvement of additional molecules whose
expression and/or interaction with PrP
C is restricted to mature
neuronal cells. In this context, the present identification of TNAP
as a neurospecific PrP
C partner posits TNAP as one such a
candidate.
Besides, our results support the notion that the onset of a
functional TNAP accompanies the serotonergic and noradrenergic
differentiation of 1C11 cells. This is substantiated by (i) the
expression of TNAP mRNAs in the differentiated progenies of the
1C11 cell line and the lack of transcripts in 1C11 precursor cells,
(ii) the selective implementation of a tetramisol-sensitive TNAP
activity during the kinetics of differentiation coinciding with
TNAP protein expression and, (iii) the participation of this
ectophosphatase to neurotransmitter metabolism. This latter
observation is in line with the well-established TNAP-mediated
regulation of pyridoxal phosphate (PLP), a cofactor of decarbox-
ylases contributing to the last step of some neurotransmitter
synthesis (serotonin, norepinephrine, GABA…). This TNAP
associated phosphomonoesterase activity may confer an important
role to this protein in the nervous system, as discussed below.
Noteworthy, our experimental design based on lipid raft
isolation shows that PrP
C and TNAP interact within these
specialized microdomains in which they segregate. The location
of PrP
C in lipid rafts or its interaction with molecules in such
microdomains has been described using other approaches. For
instance, Schmitt-Ulms et al. have investigated into PrP
C partners
in total brain samples. Their analysis confirms that PrP
C resides in
a membrane environment containing proteins specific of lipid rafts
and, in particular, a subset of molecules that, like PrP
C, use a GPI-
anchor [35]. PrP
C interacts with GM3 gangliosides present in high
amount in lymphocyte and neuronal lipid rafts [36,37] and with
other glycoproteins or glycolipids [38–40], which co-localize or are
enriched with PrP
C in rafts of neuronal cells. Whether these
partners participate in PrP
C function is however unknown.
Noticeably, different intracellular signaling molecules such as
kinases and adaptors, recruited through lipid rafts, have been
implicated in PrP
C functional interactions [3,13,20,37,41,42].
Although the functional relevance of PrP
C compartimentation
within rafts has been poorly addressed, it has recently been
established that PrP
C does recruit NCAM into lipid rafts where it
instructs Fyn activation and subsequent neurite outgrowth and
neuronal polarization [20]. Our present identification of TNAP as
a novel raft-specific PrP
C interacting molecule adds further weight
to the idea that PrP
C location in rafts deals with its neuronal
function. It is now well established that lipid rafts constitute
dynamic sub-membrane structures allowing the concentration of
specific lipids, glycolipids and glycoproteins serving particular
functions [43]. In view of the increasing set of molecules described
as interacting with PrP
C in membrane microdomains, it is
tempting to speculate that PrP
C takes part to multi-molecular
complexes whose onset is favored by the specific lipid local
composition and which may sustain signal transduction events.
Further investigation will be required to determine whether TNAP
functional interaction with PrP
C occurs directly or indirectly via
the intermediate of other proteins related to neuronal differenti-
ation programs.
An interaction of PrP
C with TNAP may have different
implications in neuronal cells in relation to the various roles
envisioned for this ectoenzyme (see fig. 10). TNAP is a
homodimeric metalloenzyme that hydrolyses phospho-monoester
specific substrates, phosphoethanolamine (PEA), inorganic phos-
phate (PPi), an important player in bone mineralization, and
pyridoxal phosphate (PLP), a cofactor of decarboxylases contrib-
uting to neurotransmitter synthesis. However, little is known about
the role of TNAP under physiological conditions and it is only
recently that this ecto-phosphatase has been recognized to be
important in the nervous system [29,44]. A role of TNAP in
neurotransmission is well illustrated by the observation that TNAP
knock-out mice develop epilepsy due to GABA deficiency [33].
These defects recall the occurrence of seizures in patients with
mutations in the ALPL gene, suffering from severe hypophospha-
tasia. Moreover, recent data show that TNAP activity is regulated
by sensory experience [29]. Since serotonin containing fibers are
Figure 9. TNAP modulates laminin phosphorylation and
binding to PrP
C in 1C11
5-HT and 1C11
NE differentiated cells.
The phosphorylation level of Laminin 1, isolated from spent medium of
undifferentiated 1C11 cells or its neuronal 1C11
5-HT serotonergic and
1C11
NE noradrenergic derivatives pre-incubated with [c-
32P]-ATP, was
detected by autoradiography as shown in (A) for untreated cells
(control) or at 48 h upon TNAP inhibition with tetramisol (+ tetramisol
(2.5 mM)). In (B) the fold increase of phopho-laminin in tetramisol
treated vs untreated cells was quantified at different times with a
PhosphorImager and the values correspond to the mean of three
independent experiments. (C) Laminin-1 was immunoprecipitated from
1C11
5-HT serotonergic and 1C11
NE noradrenergic cells left untreated
(left) or treated for 24-hr with 2.5 mM tetramisol (right) and
immunodetection was carried out with anti-PrP antibodies (SAF32).
doi:10.1371/journal.pone.0006497.g009
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suggest that TNAP could also regulate serotonin or dopamine
synthesis and participate in cortical function and neuronal
plasticity by regulating neurotransmitter synthesis. Our data
indeed establish a link between TNAP activity and bioamine
synthesis in 1C11
5-HT and 1C11
NE cells. Hence the interaction of
PrP
C with TNAP may confer to the prion protein a role in
neurotransmitter homeostasis and neuronal transmission. In this
regard, it is worthy to note that TSE-associated neurodegeneration
is accompanied by alterations in neuronal transmission notably
involving the serotonergic system [45].
Besides, TNAP could contribute to ectonucleotidase activity in
the brain [30,46,47]. Indeed, TNAP has the capacity to
dephosphorylate ATP to adenosine in a stepwise manner [48].
Nucleotide signaling exerts important neuronal function in the
development of the nervous system and in synaptic transmission in
adult brain [44]. Interestingly, a change in nucleotidase activity
has been detected in PrP
C2/2 mice which exhibit a slower rate of
ADP hydrolysis possibly leading to a lower level of adenosine [49].
Adenosine has an anticonvulsant effect and this has to be put
together with the recent observation that such PrP
C deficient mice
are more prone to develop seizures in response to convulsant
compounds [50]. The susceptibility to seizures and epilepsy recalls
the phenotype of TNAP knockout mice. Possibly, defects in TNAP
activity could account for some of the changes in brain
ectonucleotidase activities reported in hippocampal and cortical
Figure 10. Diagram depicting possible implications of a PrP
C-TNAP association in membrane microdomains of neuronal cells. PrP
C
and TNAP are GPI-anchored membrane proteins, which majorly reside in rafts. Both have been described to interact with ECM proteins [16,53,54] and
to participate to cell signaling events. PrP
C can instruct downstream signaling events, including ERK and CREB activation, by mobilizing a Cav/Fyn
complex on neurites [3,22–24]. In addition, it modulates the coupling of 5-HT receptors, with specific impact according to G protein-dependent
pathway [25]. The TNAP ectophosphatase may have different substrates. (i) By promoting PLP hydrolysis it contributes to the regulation of
neurotransmitter synthesis [33]. (ii) Its nucleotidase activity may have implications for purinergic signaling [30,46–48]. (iii) TNAP may be active on
phosphoproteins notably of the cell surface [51,52]. The identification of phospho-laminin as a TNAP substrate uncovers a novel role of this
ectoenzyme in the regulation of ECM molecules. Laminin and the laminin receptor are important components of the perineural net (PN) and are
known partners of PrP
C. The interplay between PrPC, laminin and TNAP within multiprotein complexes may have implications for neuronal functions
(survival, homeostasis, plasticity).
doi:10.1371/journal.pone.0006497.g010
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C [49]. Further investigation into
TNAP activity in a PrP
C null context should help clarify this issue.
Beyond its phospho monoesterase and ectonucleotidase activity,
TNAP may also exert a phosphatase activity on proteins [51]. This
is notably supported by the demonstration by Becq et al that
TNAP inhibition enhances the phosphorylation and concomitant
activation of the Cystic Fibrosis Trans-membrane receptor
(CFTR) [52]. Interestingly, this ectoenzyme could also have a
role on extracellular matrix proteins, as supported by its collagen-
binding domain [53,54]. In line with this, our data define
phospho-laminin as a TNAP substrate in both 1C11
5-HT and
1C11
NE neuronal cells. To our knowledge, this is the prime
evidence that TNAP may contribute to regulate the phosphory-
lation state of an ECM protein in neuronal cells. In contrast, the
partnership between PrP
C and laminin has raised much attention
over the past few years. The interaction of PrP
C with laminin has
been shown to sustain both neurite outgrowth [16], neuronal
differentiation of PC12 cells [55] and memory consolidation [56].
Whether these processes are modulated according to the
phosphorylation state of laminin remain to be investigated. Our
data support the notion that the phosphorylation level of laminin
influences its ability to interact with PrP
C and define TNAP as a
novel protagonist in the PrP
C-laminin interplay. They add to the
current notion that PrP
C may be part of large multi-molecular
complexes, depending on the cellular context and environment,
and thereby contribute to diverse cellular functions [57]. Resolving
the complexity of PrP
C partners and functional interactions in
neuronal cells should lead to a better understanding of the
neurospecificity of PrP
C function.
Materials and Methods
Cell culture and reagents
1C11 cells were grown in DMEM medium (Gibco) supple-
mented with 10% foetal calf serum (Seromed) and, differentiation
into serotonergic (1C11
5-HT) or noradrenergic (1C11
NE) neuronal
cells was induced respectively by addition of dibutyril cyclic AMP
(dbcAMP) or addition of dbcAMP in presence of 2% DMSO as
previously described [21]. Unless stated otherwise, 1C11
5-HT cells
correspond to day 4 of serotonergic differentiation and 1C11
NE
cells correspond to day 12 of noradrenergic differentiation. The
BW5147 mouse myeloma cell line was grown in RPMI containing
7.5% foetal calf serum (Gibco). For inhibition of TNAP, tetramisol
was added as indicated in the culture medium. Unless indicated,
the reagents were purchased from Sigma.
Antibodies
Mouse monoclonal antibodies specific of prion protein were
from SPI-BIO. SAF32 and SAF34 antibodies recognize an N-ter
epitope (a.a. 79–92) while Bar221 is specific of the C-ter region of
PrP
C (a.a. 140–160). N-CAM was revealed using an anti-pan N-
CAM mouse monoclonal antibody (BD Bioscience). We also used
mouse monoclonal anti-caveolin and anti-flotillin antibodies
(Transduction Laboratory) and a rabbit polyclonal antibody to
Lck (Upstate). Preparation of the anti-TNAP antibody as been
previously described [31]. Antibody MAB2549 against Laminin-1
was from R&D systems.
The secondary reagents used for immunoblot detection were,
either goat anti-mouse or goat anti-rabbit antibodies coupled to
horseradish peroxidase (HRP) accordingly to the primary
antibody, or streptavidin HRP to detect biotinylated proteins in
immune complexes and were all purchased from Southern
Biotechnology. The secondary antibodies (Molecular Probe) used
in immunofluorescence were a goat anti-mouse and a goat anti-
rabbit antibodies coupled to alexa fluo 488 (green) and alexa fluo
594 (red), respectively.
Preparation of lipid rafts (GSL) on sucrose gradient and
cell surface biotinylation
Purification of the glycosphingolipid (GSL) rich complexes was
performed as described for lymphoblastoid cells [58]. 1C11
adherent cells were washed twice in PBS then scraped on ice in
a small volume of PBS containing a cocktail of protease inhibitors
(Complete
TM from Roche) and 1 mM sodium orthovanadate
(Na3VO4) phosphatase inhibitor. Around 10
8 cells were disrupted
and homogenized at 4uC in 3 ml of MBS (Mes buffered saline):
25 mM Mes pH 6.5; 150 mM NaCl, containing 1% triton X-100
(Tx100), phosphatase and protease inhibitors. The homogenate
(HT) was clarified by 1 min centrifugation at 1000 rpm and
brought to a volume of 4 ml at 40% sucrose in MBS-Tx100. The
homogenate in 40% sucrose was transferred to a Sw41 tube
(Beckman), overlaid with 4.5 ml of a 30% sucrose solution in MBS
(without triton) then, with 2.7 ml of a third layer containing MBS
without sucrose. The step-gradient was centrifuged for 20 h at
180000 g and at 4uC in a Sw41 rotor (Beckman). The lipid rafts
containing GSL complexes appear as an opaque band 5 mm
beneath the 0%–30% layers interface. They were harvested and
diluted to a volume of 3 ml in MBS. GSL complexes were then
pelleted by centrifugation for 1 h at 300000 g in a TL100.3 rotor
(Beckman). Such raft preparations were dissolved in 6% SDS-
RIPA buffer (150 mM NaCl, 25 mM Tris HCl pH 7.4, 5 mM
EDTA, 0.5% Na-DOC and 0.5% NP40). The different soluble
fractions at 40% (F40) and 30% (F30) sucrose as well as the triton
insoluble high-speed pellet (HSP) were collected from the gradient
and their protein concentration was determined using BCA kit
(Pierce).
For analysis of PrP
C partners in lipid rafts, membrane proteins
were biotinylated prior to GSL preparation. Cells in monolayer
were washed twice with PBS Ca
2+/Mg
2+ then incubated with EZ-
link
TM-sulfo NHS-LC-biotin (Pierce) at a concentration of
0.5 mg/ml in PBS for 30 min at 4uC to limit endocytosis of
membrane receptors. Adherent biotinylated cells were washed and
GSL were isolated as above, except they were diluted in NET
buffer (150 mM NaCl, 50 mM Tris HCl pH 7.4, 5 mM EDTA)
containing 1% Tx-100 (Calbiochem) and heated 1 h at 37uCi n
order to improve solubilisation of proteins embedded into
cholesterol and to allow further immunoprecipitation of PrP
C
complexes.
Immunoprecipitation and western blot analysis
Specific immunoprecipitations were performed using protein A
or protein G sepharose beads covalently linked to anti-PrP
C IgG2a
(SAF34) or IgG1 (Bar221) respectively. This procedure avoids
recovering of IgG in the complexes which is of importance for MS
analysis. We used the Seize
TM-X protein A (or G) immunopre-
cipitating kit (Pierce) to prepare immunoabsorbant according to
the manfacturer’s recommandations. Anti-PrP coupled-beads were
then incubated overnight at 4uC with biotinylated rafts in lysis
buffer containing Tx-100. Beads were washed 4 times in high salt
buffer (NET, 1% Tx100 in 0.5 M NaCl), then twice in Hepes
40 mM before elution of the immune-complexes in a reducing
sample buffer containing SDS. For analyses in western blot, 2.5 mg
of raft proteins were immunoprecipitated while for further
purification of PrP
C partners for mass spectrometric analysis, a
high amount of raft was used (equivalent to 20–30 mg). Denatured
complexes were run on SDS-PAGE (Bio-Rad). After transfer of
proteins from the gel onto nitrocellulose membrane (Amersham),
the membrane was blocked with 1% gelatin in PBS 0.1% Tween
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C and associated proteins was
performed using streptavidin-HRP (Southern Biotechnology) 1/
100 000 and the ECL chemiluminescent procedure (Amersham).
The same SDS-PAGE and western blot procedures were used to
directly detect proteins in 15 mg of total extract prepared in NET-
T x 1 0 0l y s i sb u f f e ro ri n1mg of raft proteins prepared in 6% RIPA
buffer. After blocking, membranes were reacted with the specific
primary antibodies i.e. SAF32 (10 mg/ml), anti-N-CAM (2 mg/ml),
anti-caveolin (0.05 mg/ml), anti-flotillin (1 mg/ml), anti-Lck (0.1 mg/
ml), anti-TNAP (1/400). Immunoblots were revealed by specific
secondary antibodies coupled to HRP (1/10000) before ECL staining.
To probe an interaction of PrP
C with laminin, 1C11
5-HT and
1C11
NE cells were incubated with antibodies against laminin-1
(10 mg/ml) in PBS containing 0.5% BSA for 1 h at 4uC. Cells
were washed twice with PBS Ca
2+/Mg
2+, scrapped and collected
by centrifugation (10,000 g, 3 min, 4uC). Pellets were resuspended
in NET lysis buffer containing 1% Tx-100. Lysates were
transferred onto protein-A sepharose beads and the last steps of
immunoprecipitation were carried out as described above. SAF32
antibodies were used to detect PrP.
Mass spectrometry
Peptides were generated for mass spectrometry analysis by in-
gel trypsin digestion of proteins. Since the gel was not stained, we
used pre-stained standard molecular weight as reference to
evaluate the 80 kDa position. One mm large gel slices excised
from 8% SDS-PAGE and including proteins of interest with an
apparent molecular mass of 80 kDa, were reduced with DTT and
alkylated by iodoacetamide treatment. The enzyme digestion was
carried out overnight at 37uC with modified sequencing grade
trypsin (Promega, Madison, WI). Peptides were then extracted
from the gel by treatment with a solvent solution containing 5%
formic acid and 50% acetonitrile. The extracts were dried under
vacuum and re-suspended in a minimum volume (10 ml) of a
solution at 0.1% formic acid and 5% acetonitrile and 4 mlo f
peptide extract were analysed.
Mass spectrometric analyses were performed by LC-ESI-MS/
MS where a nanoflow liquid chromatography (LC-Packings
nanoflow LC system, Dionex Inc) is coupled to a nano
electrospray ionisation system (ESI) and a tandem mass spectrom-
eter (MS/MS) analyser (Deca XP LCQ-Ion trap mass spectrom-
eter instrument, Thermo Electron, Waltham, MA). The system
allows peptide extracts to be desalted and concentrated on a
capillary peptide trap (1 mm6300 mm ID) prior to injection on a
C18-resin (LC-Packings, Netherlands) column (15 cm675 mmI D
pepMap column). Peptides were eluted at a constant flow rate of
170 nl/min by applying a discontinuous acetonitril gradient (5%–
95%). The column exit is directly connected to the nanoelec-
trospray ion sources and the instrument is operated in data-
dependent acquisition mode to automatically switch from MS to
MS/MS analysis. MS/MS spectra were obtained by fragmenting
ion peptides by collision-induced dissociation (CID) using
normalized collision energy of 30% in the ion trap.
The data files generated by LC-MS/MS were converted to
Sequest generic format files and were confronted to the mus
musculus NCBI non-redundant database using Bioworks 3.1 Search
Engine (ThermoFinnigan). Search parameters for determination
of peptide sequences included carbamidomethyl as fixed modifi-
cation and oxidized methionine as variable modification.
PCR analysis
cDNA were reverse-transcribed using the superscript
TMII RT kit
(Invitrogen) from 5 mg of mRNA prepared from 1C11 cells and its
neuronal derivatives by Mini-Prep column purification (Quiagen).
TNAP PCR specific fragment was obtained by 23 cycles of
amplification at 62uC in a thermocycler PTL-100 (MJ research) using
the following specific primers: sense=59-GCAGGATTGACCACG
GACACTATG-39; anti-sense=59-TTCTGCTCATGGACGCCGT
GAAGC-39. As an internal control, GAPDH was amplified by 18
cycles at 58uCw i t ht h e2p r i m e r s :s e n s e=5 9-TGAAGGTCGGTGT
GAACGGATTTGGC-39; anti-sense=59-CATGTAGGCCATGA
GGTCCACCAC-39. Specific GAPDH and TNAP fragments were
run on 1% and 1.5% agarose gel respectively and revealed by BET
staining.
Enzymatic activity of alkaline phosphatase
Phosphatase activity was determined at the surface of intact cells
performing enzymatic test on cells that were cultured in 96 wells-
microplates. Cell layers were washed twice with PBS Ca
2+/Mg
2+
then incubated with CSPD chemiluminescent substrate (Roche) at
a concentration of 0.25 mM in 200 ml of a physiologic buffer
(135 mM NaCl, 4 mM KCl, 1 mM CaCl2, 20 mM Hepes
pH 7.5, 5 mM glucose and 1 mM MgCl2) as described [59]. In
order to discriminate between different phosphatase activities, the
substrate was reacted with cells with or without 5 mM tetramisol,
which inhibits TNAP and with or without 1 mM Na3VO4 which
exhibits a larger spectra of phosphatase inhibition, but is not active
on TNAP. Each condition was tested in 6 replicates. Chemilumi-
nescence amplification resulting from phosphohydrolysis of the
CSPD substrate was monitored in a Perkin Elmer reader plate.
The data are given as relative luminescent units (RLU/mg prot/h).
Membrane immunofluorescence
1C11 cells were cultured on glass cover slips at the bottom of 24
wells-micro plates and induced to differentiate into 1C11
5-HT cells.
Membrane immunofluorescence was carried out on intact cells
reacted for 1 h at room temperature with SAF32 anti-PrP (10 mg/
ml) and anti TNAP (1/100) antibodies diluted in PBS Ca
2+/Mg
2+,
2% FCS and 0.1% sodium azide to avoid internalization of
membrane receptors. After 3 washes in PBS/azide, secondary
fluorescent antibodies were added for 1 h. After washing, cells
were fixed with 3.7% formaldehyde then mounted in fluoromount
(Southern Biotechnology). Examination was carried out on an
Axiophot microscope (Zeiss) equiped with UV lamp and
appropriate emission filters for epifluorescence and with a camera
(Nikon) and video system (Packard Bell). In addition, sequential
acquisition was performed on a scanning confocal microscope
(Leica confocal SP5) at 405, 488 and 561 nm.
Determination of cellular content of bioamines and
bioaminergic precursors
1C11
5-HT or 1C11
NE cells grown in DMEM supplemented with
10% 5-HT-depleted FCS were exposed to 2.5 mM tetramisol for
up to 24 hours. This tetramisol concentration allows to fully
abrogate TNAP activity (Fig. 7) and lacks any cell toxicity (data
not shown). Cells were washed twice with PBS, scrapped and
collected by centrifugation (10,000 g, 3 min, 4uC). The levels of
serotonin (5-HT), dopamine (DA) and their precursors 5-
hydroxytryptophan (5-HTP) and dihydroxyphenylalanine (DO-
PA), respectively, were measured by HPLC with a coulometric
electrode array (ESA Coultronics, ESA Laboratories, Chelsford,
MA), as in [60]. Quantifications were made by reference to
calibration curves obtained with internal standards.
Phosphorylation of laminin
The phosphorylation state of endogenous laminin was assessed
by measuring [c-
32P]-ATP incorporation (specific activity
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1C11
5-HT or 1C11
NE cells were grown in roller bottles in serum
free conditions. [c-
32P]-ATP (1.2 GBq per 10
6 cells) was added to
the culture medium 1 hour prior tetramisol (2.5 mM) addition.
Spent medium was collected at various time points following
tetramisol treatment, concentrated by ammonium sulfate at 80%
saturation and dialyzed against 20 mM Tris-HCl pH 7.5, 0.5 M
NaCl, 0.005% Brij-35 (TNB buffer). Laminin 1 was purified from
the concentrated conditioned medium through affinity chroma-
tography using a protein A-Sepharose column (Biorad) chemically
conjugated with anti-laminin 1 antibody. Following elution,
samples were run on a 7% SDS-PAGE and incorporation of
radiolabeled phosphate was quantified using a PhophorImager
(Molecular Dynamics).
Acknowledgments
The authors wish to thank Wendy Houssin for careful reading of the
manuscript and Dr Joelle Wiels for fruitful discussions on GSL enrichment.
We also acknowledge the IFR 89 for giving us access to the Mass
Spectrometer equipment (IAL, Villejuif) and in particular we are grateful to
Dr Franc ¸ois Lenaour and Dr Pierre Eid for their expert advice in LC/MS/
MS analysis. We are greatly indebted to Dr Karine Coutant for her help as
to laminin studies and Dr Gerhardt Zu ¨rcher and Martine Bu ¨hler for
bioamine measurements. We thank Emmanuelle Perret and the ‘‘Plate-
forme d’Imagerie Dynamique, Imagopole, Institut Pasteur, Paris’’ for
confocal microscopy assistance.
Author Contributions
Conceived and designed the experiments: ME SMR JML OK. Performed
the experiments: ME AB FB JML. Analyzed the data: ME AB FB EP MP
KO BS SMR JML OK. Contributed reagents/materials/analysis tools: FB
KO OK. Wrote the paper: ME SMR JML OK.
References
1. Prusiner SB (1998) Prions. Proc Natl Acad Sci U S A 95: 13363–13383.
2. Harris DA, True HL (2006) New insights into prion structure and toxicity.
Neuron 50: 353–357.
3. Mouillet-Richard S, Ermonval M, Chebassier C, Laplanche JL, Lehmann S, et
al. (2000) Signal transduction through prion protein. Science 289: 1925–1928.
4. Lasmezas CI (2003) Putative functions of PrP(C). Br Med Bull 66: 61–70.
5. Lee KS, Linden R, Prado MA, Brentani RR, Martins VR (2003) Towards
cellular receptors for prions. Rev Med Virol 13: 399–408.
6. Taylor DR, Hooper NM (2006) The prion protein and lipid rafts. Mol Membr
Biol 23: 89–99.
7. Simons K, Ikonen E (1997) Functional rafts in cell membranes. Nature 387:
569–572.
8. Taraboulos A, Scott M, Semenov A, Avrahami D, Laszlo L, et al. (1995) Cholesterol
depletion and modification of COOH-terminal targeting sequence of the prion
protein inhibit formation of the scrapie isoform. J Cell Biol 129: 121–132.
9. Kaneko K, Vey M, Scott M, Pilkuhn S, Cohen FE, et al. (1997) COOH-
terminal sequence of the cellular prion protein directs subcellular trafficking and
controls conversion into the scrapie isoform. Proc Natl Acad Sci U S A 94:
2333–2338.
10. Gauczynski S, Hundt C, Leucht C, Weiss S (2001) Interaction of prion proteins
with cell surface receptors, molecular chaperones, and other molecules. Adv
Protein Chem 57: 229–272.
11. Capellari S, Zaidi SI, Urig CB, Perry G, Smith MA, et al. (1999) Prion protein
glycosylation is sensitive to redox change. J Biol Chem 274: 34846–34850.
12. Zanata SM, Lopes MH, Mercadante AF, Hajj GN, Chiarini LB, et al. (2002)
Stress-inducible protein 1 is a cell surface ligand for cellular prion that triggers
neuroprotection. Embo J 21: 3307–3316.
13. Spielhaupter C, Schatzl HM (2001) PrPC directly interacts with proteins
involved in signaling pathways. J Biol Chem 276: 44604–44612.
14. Meggio F, Negro A, Sarno S, Ruzzene M, Bertoli A, et al. (2000) Bovine prion
protein as a modulator of protein kinase CK2. Biochem J 352: 191–196.
15. Rieger R, Edenhofer F, Lasmezas CI, Weiss S (1997) The human 37-kDa
laminin receptor precursor interacts with the prion protein in eukaryotic cells.
Nat Med 3: 1383–1388.
16. Graner E, Mercadante AF, Zanata SM, Forlenza OV, Cabral AL, et al. (2000a)
Cellular prion protein binds laminin and mediates neuritogenesis. Brain Res Mol
Brain Res 76: 85–92.
17. Gauczynski S, Peyrin JM, Haik S, Leucht C, Hundt C, et al. (2001) The 37-
kDa/67-kDa laminin receptor acts as the cell-surface receptor for the cellular
prion protein. Embo J 20: 5863–5875.
18. Hundt C, Peyrin JM, Haik S, Gauczynski S, Leucht C, et al. (2001)
Identification of interaction domains of the prion protein with its 37-kDa/67-
kDa laminin receptor. EMBO J 20: 5876–5886.
19. Schmitt-Ulms G, Legname G, Baldwin MA, Ball HL, Bradon N, et al. (2001)
Binding of neural cell adhesion molecules (N-CAMs) to the cellular prion
protein. J Mol Biol 314: 1209–1225.
20. Santuccione A, Sytnyk V, Leshchyns’ka I, Schachner M (2005) Prion protein
recruits its neuronal receptor NCAM to lipid rafts to activate p59fyn and to
enhance neurite outgrowth. J Cell Biol 169: 341–354.
21. Mouillet-Richard S, Mutel V, Loric S, Tournois C, Launay JM, et al. (2000)
Regulation by neurotransmitter receptors of serotonergic or catecholaminergic
neuronal cell differentiation. J Biol Chem 275: 9186–9192.
22. Schneider B, Mutel V, Pietri M, Ermonval M, Mouillet-Richard S, et al. (2003)
NADPH oxidase and extracellular regulated kinases 1/2 are targets of prion
protein signaling in neuronal and nonneuronal cells. Proc Natl Acad Sci U S A
100: 13326–13331.
23. Mouillet-Richard S, Schneider B, Pradines E, Pietri M, Ermonval M, et al.
(2007) Cellular prion protein signaling in serotonergic neuronal cells.
Ann N Y Acad Sci 1096: 106–119.
24. Pradines E, Loubet D, Schneider B, Launay JM, Kellermann O, et al. (2008)
CREB-dependent gene regulation by prion protein: impact on MMP-9 and b-
dystroglycan. Cell Signal 20: 2050–2058.
25. Mouillet-Richard S, Pietri M, Schneider B, Vidal C, Mutel V, et al. (2005)
Modulation of serotonergic receptor signaling and cross-talk by prion protein.
J Biol Chem 280: 4592–4601.
26. Ermonval M, Mouillet-Richard S, Codogno P, Kellermann O, Botti J (2003)
Evolving views in prion glycosylation: functional and pathological implications.
Biochimie 85: 33–45.
27. Ermonval M, Petit D, Le Duc A, Kellermann O, Gallet PF (2008) Glycosylation-
related genes are variably expressed depending on the differentiation state of a
bioaminergic neuronal cell line: implication for the cellular prion protein.
Glycoconj J in press.
28. Balcerzak M, Hamade E, Zhang L, Pikula S, Azzar G, et al. (2003) The roles of
annexins and alkaline phosphatase in mineralization process. Acta Biochim Pol
50: 1019–1038.
29. Fonta C, Negyessy L, Renaud L, Barone P (2004) Areal and subcellular
localization of the ubiquitous alkaline phosphatase in the primate cerebral
cortex: evidence for a role in neurotransmission. Cereb Cortex 14: 595–609.
30. Langer D, Hammer K, Koszalka P, Schrader J, Robson S, et al. (2008)
Distribution of ectonucleotidases in the rodent brain revisited. Cell Tissue Res
334: 199–217.
31. Oda K, Amaya Y, Fukushi-Irie M, Kinameri Y, Ohsuye K, et al. (1999) A
general method for rapid purification of soluble versions of glycosylpho-
sphatidylinositol-anchored proteins expressed in insect cells: an application for
human tissue-nonspecific alkaline phosphatase. J Biochem (Tokyo) 126:
694–699.
32. Nakano Y, Beertsen W, van den Bos T, Kawamoto T, Oda K, et al. (2004) Site-
specific localization of two distinct phosphatases along the osteoblast plasma
membrane: tissue non-specific alkaline phosphatase and plasma membrane
calcium ATPase. Bone 35: 1077–1085.
33. Waymire KG, Mahuren JD, Jaje JM, Guilarte TR, Coburn SP, et al. (1995)
Mice lacking tissue non-specific alkaline phosphatase die from seizures due to
defective metabolism of vitamin B-6. Nat Genet 11: 45–51.
34. Trachana V, Christophorides E, Kouzi-Koliakos K, Koliakos G (2005) Laminin-
1 is phosphorylated by ecto-protein kinases of monocytes. Int J Biochem Cell
Biol 37: 478–492.
35. Schmitt-Ulms G, Hansen K, Liu J, Cowdrey C, Yang J, et al. (2004) Time-
controlled transcardiac perfusion cross-linking for the study of protein
interactions in complex tissues. Nat Biotechnol 16: 16.
36. Mattei V, Garofalo T, Misasi R, Gizzi C, Mascellino MT, et al. (2002)
Association of cellular prion protein with gangliosides in plasma membrane
microdomains of neural and lymphocytic cells. Neurochem Res 27: 743–749.
37. Mattei V, Garofalo T, Misasi R, Circella A, Manganelli V, et al. (2004) Prion
protein is a component of the multimolecular signaling complex involved in T
cell activation. .
38. Azzalin A, Ferrara V, Arias A, Cerri S, Avella D, et al. (2006) Interaction
between the cellular prion (PrP(C)) and the 2P domain K(+) channel TREK-1
protein. Biochem Biophys Res Commun 346: 108–115.
39. Keshet GI, Bar-Peled O, Yaffe D, Nudel U, Gabizon R (2000) The cellular
prion protein colocalizes with the dystroglycan complex in the brain.
J Neurochem 75: 1889–1897.
40. Loberto N, Prioni S, Bettiga A, Chigorno V, Prinetti A, et al. (2005) The
membrane environment of endogenous cellular prion protein in primary rat
cerebellar neurons. J Neurochem 95: 771–783.
41. Chen S, Mange A, Dong L, Lehmann S, Schachner M (2003) Prion protein as
trans-interacting partner for neurons is involved in neurite outgrowth and
neuronal survival. Mol Cell Neurosci 22: 227–233.
TNAP, a Neuronal PrPC Partner
PLoS ONE | www.plosone.org 12 August 2009 | Volume 4 | Issue 8 | e649742. Krebs B, Dorner-Ciossek C, Schmalzbauer R, Vassallo N, Herms J, et al. (2006)
Prion protein induced signaling cascades in monocytes. Biochem Biophys Res
Commun 340: 13–22.
43. van Deurs B, Roepstorff K, Hommelgaard AM, Sandvig K (2003) Caveolae:
anchored, multifunctional platforms in the lipid ocean. Trends Cell Biol 13:
92–100.
44. Langer D, Ikehara Y, Takebayashi H, Hawkes R, Zimmermann H (2007) The
ectonucleotidases alkaline phosphatase and nucleoside triphosphate dipho-
sphohydrolase 2 are associated with subsets of progenitor cell populations in the
mouse embryonic, postnatal and adult neurogenic zones. Neuroscience 150:
863–879.
45. Ledoux JM (2005) Effects on the serotoninergic system in sub-acute transmissible
spongiform encephalopathies: current data, hypotheses, suggestions for exper-
imentation. Med Hypotheses 64: 910–918.
46. Narisawa S, Hasegawa H, Watanabe K, Millan JL (1994) Stage-specific
expression of alkaline phosphatase during neural development in the mouse. Dev
Dyn 201: 227–235.
47. Zimmermann H, Braun N (1999) Ecto-nucleotidases—molecular structures,
catalytic properties, and functional roles in the nervous system. Prog Brain Res
120: 371–385.
48. Ohkubo S, Kimura J, Matsuoka I (2000) Ecto-alkaline phosphatase in NG108-
15 cells: a key enzyme mediating P1 antagonist-sensitive ATP response.
Br J Pharmacol 131: 1667–1672.
49. Pereira GS, Walz R, Bonan CD, Battastini AM, Izquierdo I, et al. (2001)
Changes in cortical and hippocampal ectonucleotidase activities in mice lacking
cellular prion protein. Neurosci Lett 301: 72–74.
50. Walz R, Amaral OB, Rockenbach IC, Roesler R, Izquierdo I, et al. (1999)
Increased sensitivity to seizures in mice lacking cellular prion protein. Epilepsia
40: 1679–1682.
51. Millan JL (2006) Alkaline Phosphatases: Structure, substrate specificity and
functional relatedness to other members of a large superfamily of enzymes.
Purinergic Signal 2: 335–341.
52. Becq F, Jensen TJ, Chang XB, Savoia A, Rommens JM, et al. (1994)
Phosphatase inhibitors activate normal and defective CFTR chloride channels.
Proc Natl Acad Sci U S A 91: 9160–9164.
53. Bossi M, Hoylaerts MF, Millan JL (1993) Modifications in a flexible surface loop
modulate the isozyme-specific properties of mammalian alkaline phosphatases.
J Biol Chem 268: 25409–25416.
54. Mornet E, Stura E, Lia-Baldini AS, Stigbrand T, Menez A, et al. (2001)
Structural evidence for a functional role of human tissue nonspecific alkaline
phosphatase in bone mineralization. J Biol Chem 276: 31171–31178.
55. Graner E, Mercadante AF, Zanata SM, Martins VR, Jay DG, et al. (2000b)
Laminin-induced PC-12 cell differentiation is inhibited following laser
inactivation of cellular prion protein. FEBS Lett 482: 257–260.
56. Coitinho AS, Freitas AR, Lopes MH, Hajj GN, Roesler R, et al. (2006) The
interaction between prion protein and laminin modulates memory consolidation.
Eur J Neurosci 24: 3255–3264.
57. Linden R, Martins VR, Prado MA, Cammarota M, Izquierdo I, et al. (2008)
Physiology of the prion protein. Physiol Rev 88: 673–728.
58. Clausse B, Fizazi K, Walczak V, Tetaud C, Wiels J, et al. (1997) High
concentration of the EBV latent membrane protein 1 in glycosphingolipid-rich
complexes from both epithelial and lymphoid cells. Virology 228: 285–293.
59. Scheibe RJ, Kuehl H, Krautwald S, Meissner JD, Mueller WH (2000) Ecto-
alkaline phosphatase activity identified at physiological pH range on intact P19
and HL-60 cells is induced by retinoic acid. J Cell Biochem 76: 420–436.
60. Mouillet-Richard S, Nishida N, Pradines E, Laude H, Schneider B, et al. (2008)
Prions impair bioaminergic functions through serotonin- or catecholamine-
derived neurotoxins in neuronal cells. J Biol Chem 283: 23782–23790.
TNAP, a Neuronal PrPC Partner
PLoS ONE | www.plosone.org 13 August 2009 | Volume 4 | Issue 8 | e6497